Your browser doesn't support javascript.
loading
Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes.
Gu, Jun-Xu; Huang, Juan; Wang, Kun; Yin, Yue; Fang, Jun-Ling; Zhang, Ai-Min; Li, Shan-Shan; Yao, Xiao-Qin; Yang, Ming; Zhang, Na; Jia, Mei; Su, Ming.
Afiliación
  • Gu JX; Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
  • Huang J; Department of Traditional Chinese Medicine, Peking University International Hospital, Beijing, PR China.
  • Wang K; Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, PR China.
  • Yin Y; Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
  • Fang JL; Department of Clinical Laboratory, Shunyi District Shunan Hospital, Beijing, PR China.
  • Zhang AM; Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
  • Li SS; Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
  • Yao XQ; Department of Clinical Laboratory, Shunyi District Shunan Hospital, Beijing, PR China.
  • Yang M; Department of Clinical Laboratory, Peking University International Hospital, Beijing, PR China.
  • Zhang N; Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
  • Jia M; Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
  • Su M; Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
Heliyon ; 10(17): e37415, 2024 Sep 15.
Article en En | MEDLINE | ID: mdl-39296136
ABSTRACT

Background:

High circulatory lipoprotein(a) [Lp(a)] concentration promotes atherosclerosis; however, its efficacy in predicting the extent of atherosclerotic coronary heart disease (CHD) with coronary artery obstruction and major adverse cardiovascular events (MACEs) in diabetic patients remains questionable. This study aimed to examine whether elevated circulating Lp(a) levels exacerbate CHD and to assess their utility in predicting MACEs in individuals diagnosed with type 2 diabetes mellitus (T2DM).

Methods:

In total, 4332 patients diagnosed with T2DM who underwent coronary angiography (CAG) were included and categorized into two groups (CHD and non-CHD) based on the CAG results. We used a correlation analysis to explore the potential links between the levels of circulating Lp(a) and CHD severity. Cox regression analysis was performed to evaluate MACEs.

Results:

The concentrations of circulating Lp(a) were markedly elevated in the CHD group and positively correlated with disease severity. Our results indicate that elevated circulating Lp(a) is a crucial risk factor that significantly contributes to both the progression and severity of CHD. The differences between the two groups are evident in the risk of CHD occurrence [odds ratio (OR) = 1.597, 95 % confidence interval (CI) 1.354-1.893, p < 0.001], the different levels of vessel involvement (OR = 1.908 for triple-vessel vs. single-vessel disease, 95 % CI 1.401-2.711, p < 0.001), and their relation to the Gensini Score (OR = 2.002 for high vs. low GS, 95 % CI 1.514-2.881, p < 0.001). Over the course of the 7-year follow-up period, the multivariate Cox regression analysis indicated that increased levels Lp(a) levels are independently associated with the occurrence of MACEs [hazard ratio (HR) = 1.915, 95 % CI 1.571-2.493, p < 0.001].

Conclusion:

We confirmed a positive correlation among circulating Lp(a) levels, CHD lesions count, and Gensini scores. Moreover, Lp(a) levels have predictive significance for the occurrence of MACEs in T2DM patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido